Literature DB >> 17681741

Boston naming performance distinguishes between Lewy body and Alzheimer's dementias.

Vanessa G Williams1, Jared M Bruce, Holly James Westervelt, Jennifer Duncan Davis, Janet Grace, Paul F Malloy, Geoffrey Tremont.   

Abstract

Although naming impairment is common among persons with dementia, little is known about how specific error types on naming tasks may differ between dementias. Recent research has suggested that persons with dementia with Lewy bodies (DLB) have more visuospatial/visuoperceptual dysfunction than those with Alzheimer's disease (AD), which may impact their ability to correctly perceive and name objects. Our retrospective study evaluated the presence and frequency of error types among patients with DLB and AD on the Boston Naming Test (BNT). Errors on the BNT were classified into five types (i.e., visuoperceptual, semantic, phonemic, no response, and other), and performance was compared among 31 probable DLB patients and 31 probable AD patients matched for age, gender, education, and overall dementia severity. AD patients' overall performance on the BNT was significantly worse than DLB patients (p<.05). In terms of error types, DLB patients made significantly more visuoperceptual errors (p<.05) while AD patients made significantly more semantic errors (p<.001). Logistic regression revealed that the number of visuoperceptual and semantic errors significantly predicted group membership (p<.005), with an accuracy of up to 85%. Results suggest that error analysis of BNT responses may be useful in distinguishing between patients with DLB and AD.

Entities:  

Mesh:

Year:  2007        PMID: 17681741     DOI: 10.1016/j.acn.2007.06.008

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  7 in total

1.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

Review 2.  Distinguishing Alzheimer's disease from other major forms of dementia.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

Review 3.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

4.  Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.

Authors:  Guerry M Peavy; Steven D Edland; Belinda M Toole; Lawrence A Hansen; Douglas R Galasko; Ann M Mayo
Journal:  Parkinsonism Relat Disord       Date:  2016-07-21       Impact factor: 4.891

5.  Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease.

Authors:  G A Jicha; F A Schmitt; E Abner; P T Nelson; G E Cooper; C D Smith; W R Markesbery
Journal:  Neurobiol Aging       Date:  2008-11-20       Impact factor: 4.673

6.  Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) battery.

Authors:  Natália Bezerra Mota Quental; Sonia Maria Dozzi Brucki; Orlando Francisco Amodeo Bueno
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

7.  Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging.

Authors:  Chun W Yao; Amélie Pelletier; Seyed-Mohammad Fereshtehnejad; Nathan Cross; Thanh Dang-Vu; Ronald B Postuma
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.